InsightsFrenzy.com | Discover Insightful Content

Know The FDA Approved Biosimilar Drugs For Adult ADHD

Attention deficit hyperactivity disorder or ADHD interferes with the functioning and development of the brain. The disorder affects people of any age group, and the symptoms of ADHD can be easily recognized. Adults who are diagnosed with the disease turn out to be a victim of the disorder since childhood. FDA has approved some biosimilar drugs for adult ADHD as the disorder takes a severe form in the case of adults.

Why is a diagnosis required?

In many cases, the symptoms of ADHD in children are often ignored. If the symptoms persist for extended periods, the child may have ADHD and it becomes crucial for a diagnosis. Children usually face problems to pay attention while completing a certain task, or difficulty in controlling the behavior, or they easily get involved in an intense activity. Such problems cause significant damage to the academic, social, and personal lives of the ones affected.

Biosimilar drugs for ADHD

The symptoms of ADHD can be treated with medications and therapies. Several biosimilar drugs for adult ADHD that are approved by FDA are available to treat the symptoms of ADHD. Some of these are:

FDA has approved the use of the generic drug Strattera (atomoxetine) to treat the condition of ADHD in pediatric and adult patients. The manufacturers have gained the permission of manufacturing the drug in multiple strengths. Atomoxetine must be dispensed with a patient medication guide that describes the uses and warnings of the drug.
Shire’s drug Mydayis (SHP465) has also received FDA’s approval to treat patients aged above 12 years, who suffer from ADHD. The drug contains two vital active ingredients—amphetamine and dextroamphetamine that help treat children suffering from hyperactiveness and impulsivity, which are the two major symptoms of ADHD. The therapy is formulated to stay up to 16 hours in the body.
Cotempla XR-ODT also received FDA approval to treat patients aged between 6 and 17 years. It is the first and only orally disintegrating tablet that dissolves in the patient’s mouth. Hence, this need not be chewed or dissolved in water, unlike other tablets or drugs.

These adult ADHD biosimilar drugs treat the conditions of the disorder slowly, and it is advised to seek a doctor before taking these medications.

Disclaimer:

The content provided on our blog site traverses numerous categories, offering readers valuable and practical information. Readers can use the editorial team’s research and data to gain more insights into their topics of interest. However, they are requested not to treat the articles as conclusive. The website team cannot be held responsible for differences in data or inaccuracies found across other platforms. Please also note that the site might also miss out on various schemes and offers available that the readers may find more beneficial than the ones we cover.

Popular Articles

Things You Never Knew About Biosimilar Medicines

Psoriasis has become one of the grave concerns in the US society as there are several types of this disease exist including plague, inverse, guttate and erythrodermic psoriasis. Spreading from to other parts of the body, the nails of a person are affected due to this.

What are the medications available to treat ADD and ADHD

Both attention deficit disorder (ADD) and attention deficit hyperactivity disorder (ADHD) affect the brain, causing abnormalities in focusing on things, which include schoolwork, social interactions, and everyday activities, such as brushing teeth and getting dressed.

Biosimilars Treatment for Multiple Myeloma

Multiple myeloma is a condition wherein plasma cells, which are a type of white blood cells in the bone marrow, become cancerous and start multiplying. This condition can damage the bones, immune system, and kidneys and the treatment for myeloma depends on the stage of cancer.

Significance of Biosimilars in Treatment of Multiple Myeloma

Biosimilars are a copy of the original biologic medical product used in the treatment of a particular disease. These are also known as follow-on or subsequent entry biologics. Biosimilars are officially approved versions of the original “innovator” medicines and are manufactured by a different pharmaceutical company.

Understanding ADHD

Understanding ADHD “ Having a high IQ or being intelligent does not mean ADHD is not a disability.” – Y.T. Reader’s Digest The acronym ADHD stands for Attention Deficit Hyperactivity Disorder.

The variety of ADHD medications for adults

Attention deficit hyperactivity disorder (ADHD) is known to have a negative effect on a child’s growth. However, 13% of adult men are diagnosed with the disease as well. Symptoms include finding difficulty in staying still, focusing and completing tasks start to appear from an early age, even as early as 3.